C-6KXALadder Bio
Spiroligomer molecules, synthetic peptides, targeted drug discovery
small molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-6KXA
C-6KXAC-6KXASpiroligomer molecules, synthetic peptides, targeted drug discovery
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Ladder Bio Spiroligomer molecules, synthetic peptides, targeted drug discovery
Ladder Bio has developed a chemical platform of synthetic, modular, fused-ring Spiroligomer molecules with diverse functional groups and controlled molecular shapes. The company designs and synthesizes libraries of billions of chemically diverse compounds for selective protein binding. Its platform is positioned for therapeutics and diagnostics, with features including stability, cell permeability, protease resistance, non-immunogenicity, and potential oral bioavailability.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Ladder Bio — Far from goals · Bottom quartile. Derived deterministically from 3 extracted project(s). Most-advanced status: exploratory. Band: far. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic